HI
BMRN icon

Harbour Investments’s BioMarin Pharmaceuticals BMRN Stock Holding History

Harbour Investments’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4K Sell
70
-4
-5% -$219 ﹤0.01% 3780
2026
Q1 		$4.16K Sell
74
-16
-18% -$933 ﹤0.01% 3654
2025
Q4 		$5.35K Sell
90
-2
-2% -$109 ﹤0.01% 2994
2025
Q3 		$4.98K Buy
92
+3
+3% +$172 ﹤0.01% 2988
2025
Q2 		$4.89K Sell
89
-3
-3% -$177 ﹤0.01% 2887
2025
Q1 		$6.5K Sell
92
-3
-3% -$202 ﹤0.01% 2719
2024
Q4 		$6.24K Sell
95
-11
-10% -$737 ﹤0.01% 2649
2024
Q3 		$7.45K Buy
106
+6
+6% +$502 ﹤0.01% 2481
2024
Q2 		$8.23K Sell
100
-155
-61% -$12.9K ﹤0.01% 2339
2024
Q1 		$22.3K Buy
255
+11
+5% +$985 ﹤0.01% 1907
2023
Q4 		$23.5K Buy
244
+128
+110% +$11.3K ﹤0.01% 1799
2023
Q3 		$10.3K Buy
116
+22
+23% +$1.96K ﹤0.01% 2025
2023
Q2 		$8.15K Buy
94
+1
+1% +$94 ﹤0.01% 2130
2023
Q1 		$9.04K Buy
93
+29
+45% +$3.01K ﹤0.01% 2047
2022
Q4 		$6.62K Sell
64
-13
-17% -$1.22K ﹤0.01% 2124
2022
Q3 		$6K Hold
77
– – ﹤0.01% 2095
2022
Q2 		$6K Buy
+77
New +$6.13K ﹤0.01% 2095
2021
Q4 		$11K Sell
123
-1,451
-92% -$120K ﹤0.01% 1875
2021
Q3 		$122K Buy
1,574
+124
+9% +$9.78K ﹤0.01% 1265
2021
Q2 		$121K Sell
1,450
-4
-0.3% -$317 ﹤0.01% 1297
2021
Q1 		$110K Buy
+1,454
New +$119K ﹤0.01% 1253

Other funds holding BMRN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Harbour Investments's BMRN Position: Q2 2026 in Review

Harbour Investments reduced its BioMarin Pharmaceuticals (BMRN) stake by 5.4% in Q2 2026, selling an estimated $219 and leaving 70 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #3780.

Harbour Investments first reported a position in BMRN in Q1 2021 and has held it in 21 quarters since. The position peaked at $122K in Q3 2021. 564 funds tracked by Wall St. Rank hold BMRN as of Q2 2026.

  • Harbour Investments held 70 shares of BioMarin Pharmaceuticals worth $4K as of Q2 2026.
  • Harbour Investments sold 4 BioMarin Pharmaceuticals shares in Q2 2026, an estimated $219.
  • BioMarin Pharmaceuticals made up ﹤0.01% of Harbour Investments's portfolio in Q2 2026, its #3780 holding.
  • Harbour Investments first reported a position in BioMarin Pharmaceuticals in Q1 2021 and has held it in 21 quarters since.
  • Harbour Investments's BioMarin Pharmaceuticals position peaked at $122K in Q3 2021.
  • 564 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2026.

Based on Harbour Investments's 13F filing for Q2 2026, filed 12 Aug 2026.